X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1456) 1456
Publication (85) 85
Newsletter (32) 32
Book Review (20) 20
Newspaper Article (12) 12
Conference Proceeding (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1256) 1256
formoterol fumarate (1086) 1086
male (819) 819
ethanolamines - administration & dosage (799) 799
formoterol (759) 759
administration, inhalation (753) 753
female (743) 743
asthma - drug therapy (724) 724
bronchodilator agents - administration & dosage (648) 648
index medicus (644) 644
middle aged (611) 611
adult (604) 604
asthma (584) 584
respiratory system (583) 583
ethanolamines - therapeutic use (467) 467
aged (423) 423
double-blind method (422) 422
treatment outcome (415) 415
drug combinations (400) 400
pulmonary disease, chronic obstructive - drug therapy (372) 372
bronchodilator agents - therapeutic use (369) 369
budesonide - administration & dosage (365) 365
salmeterol (352) 352
drug therapy, combination (345) 345
budesonide (334) 334
adolescent (300) 300
pharmacology & pharmacy (285) 285
ethanolamines - adverse effects (273) 273
albuterol - analogs & derivatives (256) 256
drug therapy (256) 256
albuterol - administration & dosage (244) 244
adrenergic beta-agonists - administration & dosage (236) 236
bronchodilator agents - adverse effects (224) 224
asthma - physiopathology (219) 219
copd (218) 218
nebulizers and vaporizers (218) 218
salmeterol xinafoate (216) 216
budesonide - therapeutic use (206) 206
cross-over studies (202) 202
lung diseases, obstructive (202) 202
anti-asthmatic agents - administration & dosage (200) 200
dose-response relationship, drug (199) 199
albuterol - therapeutic use (198) 198
child (195) 195
forced expiratory volume - drug effects (189) 189
time factors (186) 186
obstructive pulmonary-disease (184) 184
efficacy (183) 183
ethanolamines - pharmacology (183) 183
salbutamol (179) 179
adrenergic beta-agonists - therapeutic use (174) 174
metered dose inhalers (167) 167
adrenergic beta-2 receptor agonists - administration & dosage (166) 166
forced expiratory volume (166) 166
exacerbations (165) 165
pulmonary disease, chronic obstructive - physiopathology (164) 164
safety (164) 164
dosage and administration (162) 162
chronic obstructive pulmonary disease (161) 161
adrenal cortex hormones - administration & dosage (159) 159
corticosteroids (159) 159
drug administration schedule (157) 157
fluticasone (149) 149
care and treatment (138) 138
formoterol fumarate - administration & dosage (138) 138
pulmonary and respiratory medicine (138) 138
animals (131) 131
pulmonary/respiratory (131) 131
randomized controlled trials as topic (129) 129
aged, 80 and over (128) 128
research (126) 126
young adult (124) 124
cardiac & cardiovascular systems (123) 123
budesonide/formoterol (122) 122
anti-asthmatic agents - therapeutic use (119) 119
medicine, general & internal (118) 118
respiratory tract diseases (118) 118
single inhaler (118) 118
allergy (117) 117
androstadienes - administration & dosage (114) 114
bronchodilator agents - pharmacology (114) 114
quality of life (114) 114
severity of illness index (111) 111
antiasthmatic agents (108) 108
respiratory function tests (108) 108
therapy (108) 108
analysis (107) 107
double-blind (106) 106
glucocorticoids - administration & dosage (106) 106
budesonide - adverse effects (104) 104
adrenergic beta-agonists - adverse effects (103) 103
inhaled corticosteroids (103) 103
tiotropium (98) 98
adrenal cortex hormones - therapeutic use (97) 97
fluticasone propionate (97) 97
combination (95) 95
immunology (95) 95
metered-dose inhaler (94) 94
clinical trials (92) 92
steroids (92) 92
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1420) 1420
German (42) 42
French (10) 10
Japanese (6) 6
Spanish (6) 6
Danish (4) 4
Russian (3) 3
Chinese (2) 2
Polish (2) 2
Romanian (2) 2
Turkish (2) 2
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Respiratory Research, ISSN 1465-9921, 01/2017, Volume 18, Issue 1, p. 8
Journal Article
Respiratory research, ISSN 1465-9921, 2014, Volume 15, Issue 1, pp. 123 - 123
Background: Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic... 
Formoterol | Dyspnea | Health status | Lung function | Aclidinium | COPD | MODERATE | HYPERINFLATION | BRONCHODILATION | MAINTENANCE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TIOTROPIUM | BROMIDE | ACCORD COPD | FLUTICASONE | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | North America | Recovery of Function | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Dry Powder Inhalers | Double-Blind Method | Drug Administration Schedule | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | New Zealand | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Australia | Health Status | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Pharmaceutical industry | Medical research | Studies | Heart attacks | Laboratories | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Research
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 20, pp. 1865 - 1876
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 20, pp. 1877 - 1887
Journal Article
Respiratory Medicine, ISSN 0954-6111, 05/2018, Volume 138, pp. 74 - 80
This study compared the efficacy, pharmacokinetics (PK), and safety of GFF MDI (Bevespi Aerosphere ), a fixed-dose combination of glycopyrronium and formoterol... 
Co-suspension delivery technology | Metered dose inhaler | Formoterol fumarate dihydrate | Spacer | Valved holding chamber | Glycopyrronium | LUNG | CARDIAC & CARDIOVASCULAR SYSTEMS | CO-SUSPENSION(TM) DELIVERY TECHNOLOGY | DEPOSITION | COMBINATION | CHILDREN | RESPIRATORY SYSTEM | SPACER DEVICES | ASTHMA | COPD | Bronchodilator Agents - blood | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - blood | Metered Dose Inhalers | Female | Bronchodilator Agents - adverse effects | Muscarinic Antagonists - blood | Formoterol Fumarate - blood | Glycopyrrolate - adverse effects | Severity of Illness Index | Inhalation Spacers | Formoterol Fumarate - adverse effects | Glycopyrrolate - blood | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Aged | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Chlorofluorocarbons | Parameters | Lung diseases | Pharmacology | Glycopyrrolate | Patients | Confidence intervals | Randomization | Concentration time | Obstructive lung disease | Formoterol | Chronic obstructive pulmonary disease | Safety | Pharmacokinetics | Drug dosages
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10082, pp. 1919 - 1929
Journal Article
Journal Article
Respiratory Research, ISSN 1465-9921, 08/2017, Volume 18, Issue 1, pp. 157 - 11
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2016, Volume 120, pp. 16 - 24
Abstract Background This study formed part of the dose selection for a glycopyrrolate (GP)/formoterol fumarate (FF) fixed-dose combination formulated using... 
Pulmonary/Respiratory | Bronchodilators | Co-Suspension™ Delivery Technology | Fixed-dose combinations | LAMA | COPD maintenance therapy | LABA | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | HYPERINFLATION | VALIDATION | Co-Suspension (TM) Delivery Technology | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | OUTCOMES | GLYCOPYRRONIUM | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Tiotropium Bromide - administration & dosage | Metered Dose Inhalers - utilization | Female | Dry Powder Inhalers - methods | Glycopyrrolate - adverse effects | Double-Blind Method | Formoterol Fumarate - pharmacology | Tiotropium Bromide - adverse effects | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Tiotropium Bromide - pharmacology | Cholinergic Antagonists - administration & dosage | Cross-Over Studies | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Adrenergic beta-2 Receptor Agonists - administration & dosage | Glycopyrrolate - pharmacology | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Care and treatment | Clinical trials | Formoterol | Dosage and administration | Drug therapy, Combination | Comparative analysis | Complications and side effects | Respiratory agents | Respiratory therapy | Electrocardiography | Chronic obstructive pulmonary disease | Effectiveness | Pharmaceutical industry
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2017, Volume 42, pp. 43 - 51
Journal Article